Sign In
to Vote &
Create Storyboards.
 
(University of Houston) Of those diagnosed with a "spongy heart," 47% will die. University of Houston pharmacologist Mingfu Wu has been awarded $2.5 million from the National Heart, Lung, and Blood Institute to explore the cause of and therapeutic treatment for the heart disease officially called left ventricular non-compaction cardiomyopathy (LVNC).
0
0
0


Storyboard
Print
Share this Article

Recommended

  • {TITLE}
    {PUBLISHER} - {PUBLISHED_DATE}
    {VIEWS}
  • Create Storyboard